New papulovesicular rash in the course of COVID-19 signaling viral reactivation.
Rev Assoc Med Bras (1992)
; 67(2): 182-184, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-34406241
ABSTRACT
Cutaneous manifestations are considered an infrequent presentation of coronavirus disease 2019 (COVID-19) and are mostly described in outpatient settings. Its onset during the course of the severe COVID-19 disease has been poorly described in severe cases. Studies focused on dermatological manifestations mostly described maculopapular or pernio-like lesions and less frequently vesicular or varicella-like eruption. We described the occurrence of a vesiculopapular eruption in three laboratory-confirmed COVID-19 patients associated with severe lung injury in whom the skin findings preceded viral reactivation and recrudescence of hypoxemia. The potential mechanisms for COVID-19-related cutaneous manifestations include immune hypersensitivity, cytokine-release syndrome, deposition of microthrombi, and vasculitis.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Exanthema
/
COVID-19
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Rev Assoc Med Bras (1992)
Year:
2021
Document type:
Article
Affiliation country: